世界*實(shí)驗(yàn)材料供應(yīng)商 Worthington Biochemical 正式授權(quán)上海起發(fā)為其中國(guó)代理， Worthington Biochemical 在一直是行業(yè)的*,一直為廣大科研客戶提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國(guó)科研客戶帶來(lái)的產(chǎn)品，的服務(wù)，簽約 Worthington Biochemical 就是為了給廣大科研客戶帶來(lái)更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲
Worthington Biochemical 中國(guó)代理, Worthington Biochemical 上海代理， Worthington Biochemical 北京代理，Worthington Biochemical 廣東代理， Worthington Biochemical 江蘇代理Worthington Biochemical 湖北代理,Worthington Biochemical 天津,Worthington Biochemical 黑龍江代理,Worthington Biochemical 內(nèi)蒙古代理,Worthington Biochemical 吉林代理,Worthington Biochemical 福建代理, Worthington Biochemical 江蘇代理, Worthington Biochemical 浙江代理,Worthington Biochemical 四川代理,
Worthington組織消化指南
引言
組織消化酶主要用于組織培養(yǎng)和細(xì)胞生物學(xué)研究的原代細(xì)胞的分離和收集。盡管這些消化酶已經(jīng)普遍應(yīng)用多年，但是對(duì)其組織消化和細(xì)胞收集的作用機(jī)制卻沒(méi)有全面的理解。 由此導(dǎo)致的結(jié)果便是選擇一種消化方法大多是隨機(jī)選擇或基于過(guò)去的經(jīng)驗(yàn)，而不是在*理解消化原理的基礎(chǔ)上選擇的消化方案，以及如何根據(jù)具體實(shí)驗(yàn)?zāi)康男拚桨敢垣@得更好的實(shí)驗(yàn)結(jié)果。
細(xì)胞分離程序的目的是zui大程度的獲得功能活性的單個(gè)細(xì)胞，而影響結(jié)果的原因有很多，包括（不限于）以下：
1、組織類(lèi)型
2、物種來(lái)源
3、動(dòng)物年齡
4、遺傳改造情況（如knockouts）
5、所用的消化培養(yǎng)液
6、所用的酶
7、消化酶中的雜質(zhì)
8、所用消化酶的工作濃度
9、溫度
10、孵育時(shí)間
通常前四個(gè)原因沒(méi)辦法選擇，而剩下的原因一般由經(jīng)驗(yàn)決定以獲取zui適實(shí)驗(yàn)結(jié)果。
通過(guò)查閱文獻(xiàn)來(lái)選擇*組織消化酶和zui適消化條件的研究人員通常被互相矛盾的實(shí)驗(yàn)數(shù)據(jù)搞得一頭霧水。這些巨大差異來(lái)源于組織胞外基質(zhì)的復(fù)雜而動(dòng)態(tài)的特性，以及過(guò)去常用的粗制、未提純的組織分離酶。另外，組織胞外基質(zhì)由各種蛋白、糖蛋白、脂類(lèi)和糖脂組成，這些成分的組成比例在不同物種、不同組織、甚至不同發(fā)育（年齡）之間存在明顯的差異，這些因素都極大的影響了消化方案的制定。目前通常使用的粗制酶，如鏈霉蛋白酶、NF1:250、以及含有幾種其他不同濃度蛋白酶的膠原酶、以及各種多糖酶、核酶和脂酶。
本指南總結(jié)了目前常用組織消化酶的zui適消化和細(xì)胞收集知識(shí)和方法，描述了標(biāo)準(zhǔn)的實(shí)驗(yàn)步驟， 以便于制定一個(gè)*的細(xì)胞分離方案，同時(shí)列舉了一些相關(guān)的參考文獻(xiàn)。
下表列出多種組織的適宜消化酶（含參考文獻(xiàn)，以組織類(lèi)型和物種分類(lèi)，詳見(jiàn)鏈接）
脂肪組織 | 腎上腺組織 | 骨組織 | 腦組織 |
軟骨組織 | 結(jié)腸組織 | 內(nèi)皮組織 | 上皮組織 |
眼 | 心臟 | 腸 | 腎 |
肝 | 肺 | 淋巴結(jié) | 乳腺 |
其它組織 | 其他組織 | 肌組織 | 神經(jīng)組織 |
胰腺 | 腮腺 | 垂體 | 前列腺 |
生殖 | 動(dòng)物鱗片 | 皮膚 | 脾臟 |
干細(xì)胞 | 胸腺 | 甲狀腺/甲狀旁腺 | 扁桃體 |
腫瘤 |
|
|
|
注：使用Worthington公司消化酶的文獻(xiàn)不限于上表鏈接中所列，一般而言，Worthington公司的組織消化酶可用于大多組織類(lèi)型的消化。
腫瘤組織消化手冊(cè)
| 物種 | 詳細(xì)來(lái)源 | 細(xì)胞名稱 | 消化用酶 | 培養(yǎng)基 | 參考文獻(xiàn) |
| 倉(cāng)鼠 | 倉(cāng)鼠, 90-100 克 | Tumor | Hyaluronidase: 0.1% | Waymouth's MB | Gonzalez, A., Oberley, T., Schultz, J., Ostrom, J., and Li, J.: In VitroCharactrization of Estrogen Induced Syrian Hamster Renal Tumors: Comparison with an Immortalized Cell Line Derived from Diethylstilbestrol-Treated Adult Hamster Kidney, In Vitro Cell Dev Biol 29A, 562, 1993 |
| 倉(cāng)鼠 | 倉(cāng)鼠, 6 周大 | Buccal pouch | Neutral Protease: 0.24% | CMF HBSS | Min, B., Kim, K., Cherrick, H., and Park, N.: Three Cell Lines from Hamster Buccal Pouch Tumors Induced by Topical 7,12-Dimethylbenz(a)Anthracene, Alone or in Conjunction with Herpes Simplex Virus Inoculation, In Vitro Cell Dev Biol 27A, 128, 1991 |
| 人類(lèi) | 人類(lèi) | Non-small cell lung tumor | Collagenase Type 1: 0.1% | RPMI-1640 | Liang, S., Marti, T., Dorn, P., Froment, L., Hall, S., Berezowska, S., Kocher, G., Schmid, R. and Peng, R.: Blocking the Epithelial-to-Mesenchymal Transition Pathway Abrogates Resistance to Anti-Folate Chemotherapy in Lung Cancer., Cell Death Dis 6, e1824, 2015 |
| Collagenase Type 2: 0.25% | |||||
| 人類(lèi) | 人類(lèi) | Lung Tumor | Collagenase Type 1: 45-60 u/ml | DMEM/F12 | Quatromoni, J., Singhal, S., Bhojnagarwala, P., Hancock, W., Albelda, S. and Eruslanov, E.: An Optimized Dissagregation Method for Human Lung Tumors That Perserves the Phenotype and Function of the Immune Cells, J Leukoc Biol 97, 201, 2015 |
| Collagenase Type 2: 15-20 u/ml | |||||
| Collagenase Type 4: 45-60 u/ml | |||||
| Elastase: 0.002% | |||||
| Deoxyribonuclease I: 0.002% | |||||
| 人類(lèi) | 人類(lèi) | Glioblastoma Tumor | Trypsin: 0.025% | HBSS | Hasselbach, L., Irtenkauf, S., Lemke, N., Nelson, K., Berezovsky, A., Carlton, E., Transou, A., Mikkelsen, T. and deCarvalho, A.: Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry., J Vis Exp , e51088, 2014 |
| Collagenase Type 4: 500 u/ml | |||||
| 人類(lèi) | 人類(lèi) | Melanoma | Collagenase Type 4: 0.1% | PBS | Welte, Y., Davies, C., Schafer, R. and Regenbrecht, C.: Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma., J Vis Exp 73, e50200, 2013 |
| Deoxyribonuclease I: 0.01% | |||||
| 人類(lèi) | 人類(lèi) | Tumor | Collagenase Type 1: 0.1% | DMEM/F12 | Chou, J., Fitzgibbon, M., Mortales, C., Towlerton, A., Upton, M., Yeung, R., McIntosh, M. and Warren, E.: Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice.,PLoS ONE 8, e79874, 2013 |
| Hyaluronidase: 0.01% | |||||
| Deoxyribonuclease I: 0.01% | |||||
| 人類(lèi) | 人類(lèi) | Colorectal cancer | Collagenase Type 4: 2% | RPMI 1640 | Zhou, J, Belov, L., Solomon, M., Chan, C., Clarke, S. and Christopherson, R.: Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing., J Vis Exp 55, e3322, 2011 |
| Deoxyribonuclease I: 0.1% | |||||
| 人類(lèi) | 人類(lèi) | Tumorigenic melanoma | Collagenase Type 4: 200 u/ml | PBS | Quintana, E., Shackleton, M., Foster, H., Fullen, D., Sabel, M., Johnson, T. and Morrison, S.: Phenotypic Heterogeneity Among Tumorigenic Melanoma Cells from Patients that is Reversible and Not Hierarchically Organized., Cancer Cell 18, 510, 2010 |
| Trypsin: 0.05% | |||||
| Deoxyribonuclease I: 50-100 u/ml | |||||
| 人類(lèi) | 人類(lèi) | Pancreatic tumor | Collagenase Type 4: 200 u/ml | RPMI-1640 | Kim, M., Evans, D., Wang, H., Abbruzzese, J., Fleming, J. and Gallick, G.: Generation of Orthotopic and Heterotopic Human Pancreatic Cancer Xenografts in Immunodeficient Mice., Nat Protoc 4, 1670, 2009 |
| 人類(lèi) | 人類(lèi) | Tumor | Collagenase Type 4: 0.1% | see reference | Sauvageot, C., Weatherbee, J., Kesari, S., Winters, S., Barnes, J., Dellagatta, J., Ramakrishna, N., Stiles, C., Kung, A., Kieran, M. and Wen, P.: Efficacy of the HSP90 Inhibitor 17-AAG in Human Glioma Cell Lines and Tumorigenic Glioma Stem Cells.,Neuro Oncol Vol. 11,, , 109, 2009 |
| Hyaluronidase: 0.07% | |||||
| Deoxyribonuclease I: 0.04% | |||||
| 人類(lèi) | 人類(lèi) | Colon cancer | Collagenase Type 1: 300 u/ml | DMEM/F12 | Varnat, F., Duquet, A., Malerba, M., Zbinden, M., Mas, C., Gervaz, P. and Ruiz i Altaba, A.: Human Colon Cancer Epithelial Cells Harbour Active HEDGEHOG-GLI Signalling that is Essential for Tumour Growth, Recurrence, Metastasis and Stem Cell Survival and Expansion., EMBO Mol Med 1, 338-51, 2009 |
| Hyaluronidase: 100 u/ml | |||||
| 人類(lèi) | 人類(lèi) | Breast epithelial | Collagenase Type 3: 200 u/ml | HBSS | Liu, R., Wang, X., Chen, G., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K. and Clarke, M.: The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells., N Engl J Med 356, 217, 2007 |
| 人類(lèi) | 人類(lèi) | Prostate stromal cells | Collagenase Type 1: 0.1% | RPMI 1640 | Nakashiro Koh-Ichi, Hara Shingo, Shinohara Yuji, Oyasu Miho, Kawamata Hitoshi, Shintani Satoru, Hamakawa Hiroyuki, Oyasu Ryoichi: Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R, Am J Pathol 165, 533-40, 2004 |
| 人類(lèi) | 人類(lèi), 成年人 | Human synovial sarcoma | Collagenase Type 2: 200 u/ml | DMEM/F-12 | Nishio Jun, Iwasaki Hiroshi, Ishiguro Masko, Ohjimi Yuko, Fujita Chikako, Isayama Teruto, Naito Masatoshi, Oda Yoshinao, Kaneko Yasuhiko, Kikuchi Masahiro: Establishment of a new human synovial sarcoma cell line, FU-SY-1, that expresses c-Met receptor and its ligand hepatocyte growth factor, Int J Oncol 21, 17-23, 2002 |
| 人類(lèi) | 人類(lèi) | Colonocytes | Collagenase: | DMEM/F12 | Emenaker N, Calaf G, Cox D, Basson M and Qureshi N: Short chain fatty acids differentially modulate cellular phenotype and c-myc protein levels in primary human nonmalignant and malignant colonocytes, J Nutr 46, 96-105, 2001 |
| 人類(lèi) | 人類(lèi) | Epithelial, fibroblasts | Trypsin: 0.25% | Ham's F-12 | MacLeod, R: Rapid Monolayer Primary Cell Culture from Tissue Biopsy,Cell & Tissue Culture: Laboratory Procedures Vol. 1,Doyle, A., Griffiths, J., and Newell, D., John Wiley and Sons Ltd, 3E:2.1, 1995 |
| 人類(lèi) | 人類(lèi) | Colon adenocarcinoma | Hyaluronidase: 100 u/ml | DMEM | Hague, A and Paraskeva, C: Colon Adenocarcinoma Cells,Cell & Tissue Culture: Laboratory Procedures Vol. 1,Doyle, A., Griffiths, J., and Newell, D., John Wiley and Sons, Ltd., 12C:1.1, 1995 |
| 人類(lèi) | 人類(lèi) | Tumor, breast | Hyaluronidase: 100 u/ml | DMEM | Beaupain, R., Mainquene, C., Brouty-Boye, D., Planchon, P., and Magniew, V.: "Normal" Breast Cells Adjacent to a Tumor Grown in Long-term Three Dimensional Culture, In Vitro Cell Dev Biol 29, 100, 1993 |
| 人類(lèi) | 人類(lèi) | Glioma | Hyaluronidase: 0.01% | HBSS | Kruse, C., Mitchell, D., Kleinschmidt-DeMasteis, B., Franklin, W., Morse, H., Spector, E., and Lillehei, K.: Characterization of a Continuous Human Glioma Cell Line DBTRG-OSMG: Growth Kinetics, Karyotype, Receptor Expression and Tumor Suppressor Gene Analyses, In Vitro Cell Dev Biol 28, 609, 1992 |
| 人類(lèi) | 人類(lèi) | Epithelial | Collagenase: 2.0% | DMEM/Ham's F-12 | Emerman, J. and Wilkinson, D.: Routine Culturing of Normal, Dysplastic and Malignant Human Mammary Epithelial Cells from Small Tissue Samples,In Vitro Cell Dev Biol 26, 1186, 1990 |
| 人類(lèi) | 人類(lèi) | Tumor | Neutral Protease: 0.24% | DMEM/Ham's F-12 | Boyd, J., Rinehart Jr., C., Walton, L., Siegal, G. and Kaufman, D.:Ultrastructural Characterization of Two New Human Endometrial Carcinoma Cell Lines and Normal Human Endometrial Epithelial Cells Cultured on Extracellular Matrix, In Vitro Cell Dev Biol 26, 701, 1990 |
| 人類(lèi) | 人類(lèi), 9-74 歲 | Neurofibroma | Neutral Protease: 1.25 u/ml | L-15 | Sheela S, Riccardi VM, Ratner N: Angiogenic and invasive properties of neurofibroma Schwann cells, J Cell Biol 111, 645-53, 1990 |
| Collagenase Type 1: 0.05% | |||||
| Hyaluronidase: 0.1% | |||||
| 人類(lèi) | 人類(lèi) | Tumor | Trypsin: 0.05% | DMEM | Sacks, P., Parnes, S., Gallick, G., Mansouri, Z., Lichtner, R., Satya-Prakash, K., Pathak, S, and Parsons, D.: Establishment and Characterization of Two New Squamous Cell Carcinoma Cell Lines Derived from Tumors of the Head and Neck, Cancer Res 48, 2858, 1988 |
| 人類(lèi) | 人類(lèi) | Tumor, colon | Trypsin: 0.25% | McCoy's | Brattain, M., Marks, M., McCombs, J., Finely, W., and Brattain, D.:Characterization of Human Colon Carcinoma Cell Lines Isolated From a Single Primary Tumour, Br J Cancer 47, 373, 1983 |
| 人類(lèi) | 人類(lèi) | Epthelial and tumor | Collagenase: 300 u/ml | PBS medium 199 or medium F 12 | Friedman, E., Higgins, P., Lipkin, M., Shinya, H., and Gelb, A.: Tissue Culture of Human Epithelial Cells from Benign Colonic Tumors, In Vitro 17, 632, 1981 |
| Colon | |||||
| 人類(lèi) | 人類(lèi) | Tumor, breast | Neuraminidase: 0.8 u/ml | HBSS | Leung, C., and Shiu, R.: Morphological and Proliferative Characteristics of Human Breast Tumor Cells Cultured on Plastic and in Collagen Matrix, In Vitro 18, 476, 1981 |
| 人類(lèi) | 人類(lèi) | Melanoma | Collagenase Type 3: 0.10% | DMEM | Creasey, A., Smith, H., Hackett, A., Fukuyama, K., Epstein, W., and Madin, S.: Biological Properties of Human Melanoma Cells in Culture, In Vitro 15, 342, 1979 |
| Metastatic tumors | |||||
| 人類(lèi) | 人類(lèi) | Mammary tumors, hard | Collagenase: 0.10% | RPMI-1640 w/ 5% Fetal Calf Serum | Lasfargues, E.: Tissue Culture Methods/Applications,Kruse, P., and Patterson, M., Academic Press, 45, 1973 |
| 小鼠 | 小鼠 | Fibroblasts | Collagenase Type 2: 0.25% | DMEM | Sharon, Y., Alon, L., Glanz, S., Servais, C. and Erez, N.: Isolation of Normal and Cancer-Associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting (FACS)., J Vis Exp 71, e4425, 2013 |
| Collagenase Type 4: 0.25% | |||||
| Deoxyribonuclease I: 0.05% | |||||
| 小鼠 | 小鼠 | Prostate tumor | Collagenase Type 4: 1,600 u/ml | DMEM/F12 | Mazzoleni, S., Jachetti, E., Morosini, S., Grioni, M., Piras, I., Pala, M., Bulfone, A., Freschi, M., Bellone, M. and Galli, R.: Gene Signatures Distinguish Stage-Specific Prostate Cancer Stem Cells Isolated From Transgenic Adenocarcinoma of the Mouse Prostate Lesions and Predict the Malignancy of Human Tumors., Stem Cells Transl Med 2, 678, 2013 |
| 小鼠 | 小鼠 | Mammary tumor | Collagenase: 0.15% | DMEM/F12 | Liu, X., Johnson, S., Liu, S., Kanojia, D., Yue, W., Singh, U., Wang, Q, Wang Qi, Nie, Q. and Chen H.: Nonlinear Growth Kinetics of Breast Cancer Stem Cells: Implications for Cancer Stem Cell Targeted Therapy.,Sci Rep 3, 2473, 2013 |
| Hyaluronidase: 0.020% | |||||
| 小鼠 | 小鼠 | Rhabdomycosarcoma tumor | Trypsin: 0.012% | DMEM | Chen, X., Stewart, E., Shelat, A., Qu, C., Bahrami, A., Hatley, M., Wu, G., Bradley, C., McEvoy, J., Pappo, A., Spunt, S., Valentine, M., Valentine, V., Krafcik, F., Lang, W., Wierdl, M. and Tsurkan, L.:Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma., Cancer Cell24, 710-24, 2013 |
| Collagenase Type 2: 0.1% | |||||
| 小鼠 | 小鼠 | Tumor endothelial | Collagenase Type 1: 0.2% | HBSS | Kazerounian, S., Gerald, D., Huang, M., Chin, R, Udayakumar, D, Zheng, N., O'Donnell, R., Perruzzi, C., Mangiante, L., Pourat, J., Phung, T., Bravo-Nuevo, A., Shechter, S., McNamara, S. and Duhadaway, K.:RhoB Differentially Controls Akt Function in Tumor Cells and Stromal Endothelial Cells During Breast Tumorigenesis., Cancer Res 73, 50, 2013 |
| 小鼠 | 小鼠, 雄性 | Dendritic, macrophages | Collagenase (1 or 4): 100-200 u/ml | RPMI | Watkins, S., Zhu, Z., Watkins, K. and Hurwitz, A.: Isolation of Immune Cells from Primary Tumors., J Vis Exp 64, e3952, 2012 |
| Deoxyribonuclease I: 0.01% | |||||
| 小鼠 | 小鼠 | Lung tumor | Neutral Protease: 50 u/ml | DMEM | Vaughan, A., Halbert, C., Wootton, S. and Miller, A.: Lung Cancer in Mice Induced by the Jaagsiekte Sheep Retrovirus Envelope Protein is not Maintained by Rare Cancer Stem Cells, but Tumorigenicity does Correlate with Wnt Pathway Activation., Mol Cancer Res 10, 86, 2012 |
| Collagenase: 400 u/ml | |||||
| Deoxyribonuclease I: 50 u/ml | |||||
| 小鼠 | 小鼠 | Macrophages | Collagenase Type 4: 0.2% | PBS | Hamzah, J., Kotamraju, V., Seo, J., Agemy, L., Fogal, V., Mahakian, L., Peters, D., Roth, L., Gagnon, M., Ferrara, K. and Ruoslahti, E.: Specific Penetration and Accumulation of a Homing Peptide Within Atherosclerotic Plaques of Apolipoprotein E-deficient Mice., Proc Natl Acad Sci U S A 108, 7154, 2011 |
| 小鼠 | 小鼠 | Pancreatic Cancer Stem | Collagenase Type 4: 200 u/ml | DMEM | Rasheed, Z., Wang, Q. and Matsui, W.: Isolation of Stem Cells from Human Pancreatic Cancer Xenografts., J Vis Exp 43, 2169, 2010 |
| Neutral Protease: 0.6 u/ml | |||||
| 小鼠 | 小鼠 | Tumor infiltration lymphocytes | Collagenase Type 1: 0.25% | RPMI 1640 | Kwong, B., Roberts, S., Silberzahn, T., Filler, R., Neustadter, J., Galan, A., Reddy, S., Lin, W., Ellis, P., Langford, C., Hayday, A. and Girardi, M.:Molecular Analysis of Tumor-Promoting CD8+ T cells in Two-Stage Cutaneous Chemical Carcinogenesis., J Invest Dermatol 130, 1726, 2010 |
| Collagenase Type 2: 0.15% | |||||
| Collagenase Type 4: 0.1% | |||||
| Hyaluronidase: 0.025% | |||||
| 小鼠 | 小鼠, 4-6 周 | Pancreatic tumor | Collagenase Type 4: 200 u/ml | RPMI-1640 | Kim, M., Evans, D., Wang, H., Abbruzzese, J., Fleming, J. and Gallick, G.: Generation of Orthotopic and Heterotopic Human Pancreatic Cancer Xenografts in Immunodeficient Mice., Nat Protoc 4, 1670, 2009 |
| 小鼠 | 小鼠 | Tumor | Collagenase Type 3: 200 u/ml | RPMI-1640 | Prince, M., Sivanandan, R., Kaczorowski, A., Wolf, G., Kaplan, M., Dalerba, P., Weissman, I., Clarke, M. and Ailles, L.: Identification of a Subpopulation of Cells with Cancer Stem Cell Properties in Head and Neck Squamous Cell Carcinoma., Proc Natl Acad Sci U S A 104, 973, 2007 |
| 小鼠 | 小鼠, 30 周 | Tumor endothelial | Collagenase Type 4: 500 u/ml | PBS | Berger, M., Bergers, G., Arnold, B., Hammerling, G. and Ganss, R.:Regulator of G-protein Signaling-5 Induction in Pericytes Coincides With Active Vessel Remodeling During Neovascularization, Blood 105, 1094, 2005 |
| Collagenase Type 2: 550 u/ml | |||||
| Deoxyribonuclease I: 3 u/ml | |||||
| 小鼠 | 小鼠 | Granule cell precursors, pre-neoplastic and tumor cells | Papain: 10 u/ml | Neurobasal/B27 | Oliver, T., Read, T., Kessler, J., Mehmeti, A., Wells, J., Huynh, T., Lin, S. and Wechsler-Reya, R.: Loss of Patched and Disruption of Granule Cell Development in a Pre-Neoplastic Stage of Medulloblastoma.,Development 132, 2425, 2005 |
| Deoxyribonuclease I: 250 u/ml | |||||
| 小鼠 | 小鼠, 8-10 周 | Tumor associated endothelial cells | Collagenase Type 2: | see reference | Hida Kyoko, Hida Yasuhiro, Amin Dhara N, Flint Alan F, Panigrahy Dipak, Morton Cynthia C, Klagsbrun Michael: Tumor-associated endothelial cells with cytogenetic abnormalities, Cancer Res 64, 8249-55, 2004 |
| 小鼠 | 小鼠 | Pancreatic tumor | Collagenase Type 2: 0.5% | PBS | Bergers Gabriele, Song Steven, Meyer-Morse Nicole, Bergsland Emily, Hanahan Douglas: Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors, J Clin Invest 111, 1287-95, 2003 |
| Collagenase Type 4: 0.5% | |||||
| Deoxyribonuclease I: 0.2% | |||||
| 小鼠 | 小鼠 | Tumor-infiltrating lymphocyte | Collagenase: 200 u/ml | RPMI 1640 | Uekusa Yasuhiro, Yu Wen-Gong, Mukai Takao, Gao Ping, Yamaguchi Nobuya, Murai Masako, Matsushima Kouji, Obika Satoshi, Imanishi Takeshi, Higashibata Yuji, Nomura Shintaro, Kitamura Yukihiko, Fujiwara Hiromi, Hamaoka Toshiyuki: A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice, Cancer Res 62, 3751-8, 2002 |
| 小鼠 | 小鼠, 雄性 | Melanoma tumor cells | Collagenase Type 2: 0.5% | DMEM | Arbiser JL, Raab G, Rohan RM, Paul S, Hirschi K, Flynn E, Price ER, Fisher DE, Cohen C, Klagsbrun M: Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity, Am J Pathol 155, 723-9, 1999 |
| 小鼠 | 小鼠 (BALB/cfC3H) | Mammary tumors | Collagenase: 1.0% | HBSS | Yang, J., Guzman, R., Richards, J., and Nandi, S.: Primary Cultures of Mouse Mammary Tumor Epithelial Cells Embedded in Collagen Gels, In Vitro 16, 502, 1980 |
| Epithelial | |||||
| 小鼠 | 小鼠, BALB/cfC3H/Crgl | Neoplastic | Trypsin: | DMEM | Hosick, H.: A Note on Growth Patterns of Epithelial Tumor Cells in Primary Culture, Cancer Res 34, 259, 1974 |
| Epithelial tumor | |||||
| 小鼠 | 小鼠, 哺乳（期）, 14 天 | Mammary | Trypsin NF 1:250: 0.25% | HBSS | Kopelovich, L., Abraham, S., McGrath, H., DeOme, K., Chaikoff, I.:Metabolic Characteristics of a Naturally Ocurring Preneoplastic Tissue. I. Glycolytic Enzyme Activators of Hyperplastic Alveolar Nodule Outgrowths and Adenocarcinomas of Mouse Mammary Gland, Cancer Res 26, 1534, 1966 |
| 大鼠 | 大鼠, 成年的 | Tumor | Collagenase Type 1: 0.16% | DMEM/F12 | Duarte, S., Momier, D., Baque, P., Casanova, V., Loubat, A., Samson, M., Guigonis, J., Staccini, P., Saint-Paul, M., De Lima, M., Carle, G. and Pierrefite-Carle, V.: Preventive Cancer Stem Cell-Based Vaccination Reduces Liver Metastasis Development in a Rat Colon Carcinoma Syngeneic Model., Stem Cells 31, 423-32, 2013 |
| Hyaluronidase: 0.002% | |||||
| Deoxyribonuclease I: 0.006% | |||||
| 大鼠 | 大鼠, 雄性 12 周 | Sponge infiltrating cells | Collagenase Type 4: 0.15% | RPMI 1640 | Sharma N, Luo J, Kirschmann DA, O'Malley Y, Robbins ME, Akporiaye ET, Lubaroff DM, Heidger PM, Hendrix MJ: A novel immunological model for the study of prostate cancer, Cancer Res 59, 2271-6, 1999 |
| Deoxyribonuclease I: 0.02% | |||||
| 大鼠 | 大鼠 (ACI/NMs X BUF/Mna) F1, 雄性, 28 個(gè)月, 大鼠, (ACI/MNs) 雄性, 8 周 | Epthelial | Collagenase Type 3: 0.1% | Eagle's MEM Serum-free | Masuda, A., Ohtsuka, K., and Matsuyama, M.: Establishment of Functional Epithelial Cell Lines from a Rat Thyoma and a Rat Thymus, In Vitro Cell Dev Biol 26, 713, 1990 |
| 大鼠 | 大鼠 | Yolk sac tumor | Trypsin: 0.01% | DMEM | Brennan, M., Oldberg, A., Hayman, E., and Ruoslahti, E.: Effect of a Proteoglycan Produced by Rat Tumor Cells on Their Adhesion to Fibronectin-Collagen Substrata, Cancer Res 43, 4302, 1983 |
| 大鼠 | 大鼠, SD, 雌性 | Epithelial, cancer and tumor | Collagenase: 0.1% | Eagles's MEM | Cohen, L.: Isolation and Characterization of a Serially C*ted, Neoplastic, Epithelial Cell Line from the N-nitrosomethylurea Induced Rat Mammary Adenocarcinoma, In Vitro 18, 565, 1982 |
| 大鼠 | 大鼠 | Tumor, islet | Trypsin: 0.05% | Medium 199 | Gazdar, A., Chick, W., Oie, H., Sims, H., King, D., Weir, G., and Lauris, V.: Continuous, Clonal, Insulin-and Somatostatin-Secreting Cell Lines Established from a Transplantable Rat Islet Cell Tumor, Proc Natl Acad Sci U S A 77 (6), 3519, 1980 |
| 大鼠 | 大鼠 | Ascites hepatoma | Trypsin: 0.1% | Phosphate buffer (see reference) | Essner, E.: Experiments on an Ascites Hepatoma. I. Enzymatic Digestion and Alkaline Degradation of the Cementing Substance and Separation of Cells, in Tumor Islands, Exp Cell Res 7, 430, 1954 |
我們公司zui大優(yōu)勢(shì)是強(qiáng)大的采購(gòu)，
1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，
2：貨品全，現(xiàn)經(jīng)營(yíng)過(guò)700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，
3：提供加急服務(wù)，一般1-2周到貨，超過(guò)時(shí)限加急費(fèi)全免
4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽](méi)有服務(wù).
5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥 ，fisher等500多家公司
6：我們還是Santa,Advanced Biotechnologies Inc, Worthington Biochemical ,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. Dako,Inc, GePromegaridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,Worthington Biochemical , Polysciences,prospecbi, QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國(guó)外公司授權(quán)代理。
7：我們還是invitrogen,qiagen,Worthington Biochemical am,sigma;Promega,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發(fā)，歡迎合作。
